These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30337447)

  • 1. Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.
    Planquette B; Sanchez O; Marsh JJ; Chiles PG; Emmerich J; Le Gal G; Meyer G; Wolfson T; Gamst AC; Moore RE; Gugiu GB; Morris TA
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism.
    Chopard R; Genet B; Ecarnot F; Chatot M; Napporn G; Hyvert A; Didier-Petit K; Schiele F; Meneveau N
    Am J Cardiol; 2017 Jun; 119(11):1883-1889. PubMed ID: 28400030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.
    Meneveau N; Ider O; Seronde MF; Chopard R; Davani S; Bernard Y; Schiele F
    Eur Heart J; 2013 Mar; 34(9):693-701. PubMed ID: 23103660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Bonnefoy PB; Margelidon-Cozzolino V; Catella-Chatron J; Ayoub E; Guichard JB; Murgier M; Bertoletti L
    Thromb Res; 2019 Dec; 184():67-76. PubMed ID: 31710860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after pulmonary embolism.
    Fang A; Mayorga-Carlin M; Han P; Cassady S; John T; LaRocco A; Etezadi V; Jones K; Nagarsheth K; Toursavadkohi S; Jeudy J; Anderson D; Griffith B; Sorkin JD; Sarkar R; Lal BK; Cires-Drouet RS
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101665. PubMed ID: 37595746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
    J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Picart G; Robin P; Tromeur C; Orione C; Raj L; Ferrière N; Le Mao R; Le Roux PY; Le Floch PY; Lemarié CA; Nonent M; Leroyer C; Guegan M; Lacut K; Salaün PY; Couturaud F
    Thromb Res; 2020 Oct; 194():1-7. PubMed ID: 32554255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism.
    Chang Y; Moon JY; Park JH; Choi S; Lee HP; Sim JK; Lee YS
    J Thorac Dis; 2021 Jul; 13(7):4217-4227. PubMed ID: 34422350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Residual Pulmonary Vascular Obstruction after Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality.
    Ho TA; Pescatore J; Lio KU; Rali P; Criner G; Gayen S
    J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064289
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.
    Morris TA; Marsh JJ; Chiles PG; Magaña MM; Liang NC; Soler X; Desantis DJ; Ngo D; Woods VL
    Blood; 2009 Aug; 114(9):1929-36. PubMed ID: 19420351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a risk prediction model for residual pulmonary vascular obstruction after regular anticoagulant therapy for non-high-risk pulmonary embolism.
    Zhu D; Feng J; Guo J; Duan J; Yang Y; Leng J
    J Thorac Dis; 2024 Jul; 16(7):4447-4459. PubMed ID: 39144299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Pulmonary Vascular Obstruction Following Mechanical Thrombectomy for Submassive Pulmonary Embolism: A Single-Center Analysis.
    Stegman B; Kumar A; Dahle T; Schmidt W; Dutcher J; Glenz T; Appelbaum D
    J Soc Cardiovasc Angiogr Interv; 2024 Feb; 3(2):101260. PubMed ID: 39132216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-Based Biomarkers for Prediction of Chronic Thromboembolic Pulmonary Hypertension After an Acute Pulmonary Embolic Event.
    Lorenz G; Saeedan MB; Bullen J; Klok FA; Kroft LJM; Meijboom LJ; Heresi GA; Sripariwuth A; Renapurkar RD
    AJR Am J Roentgenol; 2020 Oct; 215(4):800-806. PubMed ID: 32809861
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
    Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
    PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells.
    Firth AL; Yau J; White A; Chiles PG; Marsh JJ; Morris TA; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L979-86. PubMed ID: 19363122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease.
    Claeys M; Claessen G; La Gerche A; Petit T; Belge C; Meyns B; Bogaert J; Willems R; Claus P; Delcroix M
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1444-1456. PubMed ID: 30219401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia as an independent predictor of adverse outcomes in pulmonary embolism.
    Subramanian M; Ramadurai S; Arthur P; Gopalan S
    Asian Cardiovasc Thorac Ann; 2018 Jan; 26(1):38-43. PubMed ID: 29260572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism.
    Abul Y; Ozsu S; Korkmaz A; Bulbul Y; Orem A; Ozlu T
    Chron Respir Dis; 2014 May; 11(2):73-81. PubMed ID: 24595892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Acute to Chronic Thromboembolic Disease.
    Fernandes T; Planquette B; Sanchez O; Morris T
    Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S207-14. PubMed ID: 27571002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.